US 11253508
PPARy agonist for treatment of progressive supranuclear palsy
granted A61KA61K31/47A61K49/0004
Quick answer
US patent 11253508 (PPARy agonist for treatment of progressive supranuclear palsy) held by Coherus BioSciences, Inc. expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Coherus BioSciences, Inc.
- Grant date
- Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/47, A61K49/0004, A61P, A61P25/28